|
91
|
Product specific BE guideline |
Entecavir Tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
92
|
Product specific BE guideline |
Levofloxacin Tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
93
|
Product specific BE guideline |
Methylphenidate ER Tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
94
|
Product specific BE guideline |
Oseltamivir Phosphate capsule_生體相等性試驗指導原則
|
2025-09-24 |
|
95
|
Product specific BE guideline |
Pazopanib tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
96
|
Product specific BE guideline |
Sitagliptin phosphate tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
97
|
Product specific BE guideline |
Tenofovir Disoproxil Fumarate Tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
98
|
Product specific BE guideline |
Ezetimibe+Simvastatin Tablets_生體相等性試驗指導原則_v2(新增QA)
|
2025-09-24 |
|
99
|
Product specific BE guideline |
Ezetimibe Tablets_生體相等性試驗指導原則_v2(新增QA)
|
2025-09-24 |
|
100
|
Statistics |
臨床試驗統計指導原則(第二版)
|
2025-09-24 |
